DNP Morning
Natural health product licensed in Canada
- Licence holder
- E. Excel LLC
- NPN or DIN-HM
- 80035056
- Status
- Active licence
- Licence date
- 29 August 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Perilla frutescens (L.) Britton: Seule l'utilisation du chemotype aldéhyde est autorisée
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Senna tora Source : Graine(s) | 30 mg | Not calculated |
| Angelica sinensis Source : Racine | 43 mg | Not calculated |
| Glycyrrhiza glabra Source : Racine | 12 mg | Not calculated |
| Perilla frutescens Source : Feuille | 30 mg | Not calculated |
| Chrysanthemum x morifolium Source : Fleur | 15 mg | Not calculated |
| Panax ginseng Source : Racine Extraction ratio : 3:1 Dry plant equivalent : 90 mg | 30 mg | Not calculated |
| Citrus reticulata Source : Pelure (fruit) | 25 mg | Not calculated |
Non-medicinal ingredients
Fleur de Cucurbita moschata, Cellulose, microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 6 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Ginger is traditionally used in Herbal Medicine to help relieve digestive upset/disturbances including, lack of appetite. nausea, digestive spasms, indigestion, dyspepsia and flatulent colic (carminative). Ginger is traditionally used in Herbal Medicine as an expectorant and anti-tussive to help relieve bronchitis as well as coughs and cold. Panax ginseng is used in Herbal Medicine as supportive therapy for promotion of health glucose levels. Panax ginseng is used in Herbal Medicine to help support cognitive function and/or reduce mental fatigue in cases of mental stress. Panax ginseng is used in Herbal Medicine to help enhance physical capacity/performance in cases of physical stress.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80035056
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.